How Acquisition Finance Preserves Cash, Creates Refinancing Claims and Transfers Repayment into Equity

When a European defence company announces a capital raise, the headline number tells its investors almost nothing about what it can now build. The figure is a nominal amount of securities. What decides the company's capacity to act is a different set of quantities: the cash that actually crossed the boundary into the business, the portion already spoken for before it arrived, the claims the raise was meant to settle, and the form in which those claims will eventually be discharged. Those quantities diverge — not by accident or concealment, but because they are written into the terms of the instruments themselves.

Take a convertible bond. At issuance it can be split into an equity component and a financial liability; the liability carries a coupon and a reset formula, and a conversion right sits over the top. The same instrument therefore appears in the issuer's accounts as debt now and as potential equity later — and the "later" is governed by a conversion ratio, not by the headline. In one worked case the conversion corresponds to roughly 4.706 million share equivalents. That figure is not a forecast of dilution: adjustments can change the ratio, existing shares can be delivered instead of new ones, and the issuer may settle in cash. It quantifies exposure, not outcome.

So "raised a given amount" is really three numbers at once. Gross proceeds are reduced by fees and by sums immediately committed to refinancing existing claims; net new cash is what actually funds building; and the repayment obligation may be discharged in cash, in new shares, or by conversion — each with a different effect on ownership and on the balance sheet. A company can announce a large raise and add very little spendable capacity, or announce a modest one and materially change what it can do, depending entirely on the structure beneath the number.

For an investor, this is the difference between reading a press release and reading the instrument. Two companies that "raised the same amount" can have opposite capacity to act and opposite dilution paths, because the cash that arrived, the cash already committed, and the way repayment converts into equity are all set by terms the headline never mentions. For a counterparty or an acquirer, the refinancing claims a raise creates — and the form in which they will be discharged — are part of what is being bought.

That is why the announcement is marketing and the terms are the asset. Preserving cash, creating a refinancing claim and transferring repayment into equity are three deliberate design choices; a reader who cannot see them is valuing a company on a number that was chosen precisely because it looks larger than the capacity it represents.

None of this is hidden; it is simply not in the headline. An issuer that wanted investors to see net spendable capacity would publish the four figures directly — cash in, cash pre-committed, the claim created, the discharge mechanism — and the fact that companies rarely do is itself information about which number they would prefer the market to anchor on. Reading the terms is not forensic suspicion; it is just refusing to value a business on the one figure chosen to look largest.

This analysis works through those mechanics deliberately, and leaves the reader with the questions that decide the money:

• How much of an announced defence capital raise is net new cash, once fees and pre-committed refinancing are stripped out?
• When a convertible is split into equity and liability at issuance, what actually determines eventual dilution — and why is the share-equivalent figure not a forecast?
• In what form will a raise's repayment claims be discharged — cash, new shares, or conversion — and who bears each outcome?
• Why can two companies that "raised the same amount" end up with opposite capacity to build and opposite ownership paths?